PT96723A - Metodo para a destoxificacao de um antigenio toxico - Google Patents

Metodo para a destoxificacao de um antigenio toxico

Info

Publication number
PT96723A
PT96723A PT96723A PT9672391A PT96723A PT 96723 A PT96723 A PT 96723A PT 96723 A PT96723 A PT 96723A PT 9672391 A PT9672391 A PT 9672391A PT 96723 A PT96723 A PT 96723A
Authority
PT
Portugal
Prior art keywords
detoxification
toxic antigen
detoxified
pertussis toxin
antigen
Prior art date
Application number
PT96723A
Other languages
English (en)
Other versions
PT96723B (pt
Inventor
Carine Capiau
Jean Petre
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of PT96723A publication Critical patent/PT96723A/pt
Publication of PT96723B publication Critical patent/PT96723B/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/099Bordetella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K2039/10Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
PT96723A 1990-02-12 1991-02-08 Metodo para a destoxificacao de um antigenio toxico PT96723B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47909890A 1990-02-12 1990-02-12

Publications (2)

Publication Number Publication Date
PT96723A true PT96723A (pt) 1991-10-31
PT96723B PT96723B (pt) 1998-07-31

Family

ID=23902647

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96723A PT96723B (pt) 1990-02-12 1991-02-08 Metodo para a destoxificacao de um antigenio toxico

Country Status (17)

Country Link
EP (1) EP0515415B1 (pt)
JP (1) JP3035712B2 (pt)
KR (1) KR100202052B1 (pt)
AT (1) ATE129159T1 (pt)
AU (1) AU646019B2 (pt)
CA (1) CA2075711C (pt)
CY (1) CY1935A (pt)
DE (1) DE69113991T2 (pt)
DK (1) DK0515415T3 (pt)
ES (1) ES2080941T3 (pt)
GR (1) GR3018440T3 (pt)
HK (1) HK1004524A1 (pt)
IE (1) IE70672B1 (pt)
NZ (1) NZ237069A (pt)
PT (1) PT96723B (pt)
WO (1) WO1991012020A1 (pt)
ZA (1) ZA91947B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT835663E (pt) 1992-05-23 2010-01-04 Glaxosmithkline Biolog Sa Vacinas combinadas compreendendo o antigénio de superfície da hepatite b e outros antigénios
GB9216351D0 (en) * 1992-07-31 1992-09-16 Wellcome Found Vaccine production
JP4601823B2 (ja) * 1998-09-01 2010-12-22 メリオン リサーチ スリー リミテッド 経口ワクチン組成物
AU769539B2 (en) * 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
GB0313916D0 (en) 2003-06-16 2003-07-23 Glaxosmithkline Biolog Sa Vaccine composition
US9475848B2 (en) 2012-02-01 2016-10-25 Glaxosmithkline Biologicals S.A. Fermentation process for producing a virulence factor from bordetella
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
AU2013301312A1 (en) 2012-08-06 2015-03-19 Glaxosmithkline Biologicals S.A. Method for eliciting in infants an immune response against RSV and B. pertussis
US8916173B2 (en) 2013-03-08 2014-12-23 Crucell Holland B.V. Acellular pertussis vaccine
US9849066B2 (en) 2013-04-24 2017-12-26 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
KR20160040290A (ko) 2013-08-05 2016-04-12 글락소스미스클라인 바이오로지칼즈 에스.에이. 조합 면역원성 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070454A (en) * 1973-05-04 1978-01-24 Agence Nationale De Valorisation De La Recherche (Anvar) Vaccines, the process for preparing the same and the applications thereof
JPS5750925A (en) * 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
US4888169A (en) * 1986-10-14 1989-12-19 Norden Laboratories, Inc. Bordetella Bronchiseptica vaccine
WO1990009444A1 (en) * 1989-02-10 1990-08-23 Genesit Oy A method for producing pertussis toxin subunits

Also Published As

Publication number Publication date
EP0515415B1 (en) 1995-10-18
CY1935A (en) 1991-02-07
AU7211091A (en) 1991-09-03
HK1004524A1 (en) 1998-11-27
IE70672B1 (en) 1996-12-11
KR100202052B1 (ko) 1999-06-15
WO1991012020A1 (en) 1991-08-22
ATE129159T1 (de) 1995-11-15
DE69113991T2 (de) 1996-03-21
DK0515415T3 (da) 1995-11-27
PT96723B (pt) 1998-07-31
JP3035712B2 (ja) 2000-04-24
KR920703099A (ko) 1992-12-17
JPH05503936A (ja) 1993-06-24
CA2075711C (en) 2000-11-07
NZ237069A (en) 1993-07-27
DE69113991D1 (de) 1995-11-23
ZA91947B (en) 1992-01-29
EP0515415A1 (en) 1992-12-02
AU646019B2 (en) 1994-02-03
CA2075711A1 (en) 1991-08-13
GR3018440T3 (en) 1996-03-31
ES2080941T3 (es) 1996-02-16
IE910424A1 (en) 1991-08-14

Similar Documents

Publication Publication Date Title
NO1997010I1 (no) Bordetella pertussis P69 antigen
PT96723A (pt) Metodo para a destoxificacao de um antigenio toxico
DE69022106D1 (de) Pertussistoxin-Mutanten, dieselbe produzierende Bordetella-Stämme und ihre Verwendung als Vakzin gegen Pertussis.
DE3785157D1 (de) Verfahren zur herstellung von toxoid.
NO872919L (no) Fremstilling av pertussis-toksin ved dyrkning av bodella pertussis.
DK520480A (da) Fremgangsmaade til fremstilling af 2,3-dihydro2,2-dimethyl-7-hydroxybenzofuran
ES523264A0 (es) Procedimiento para la preparacion de 2-(3-piridil)-1,3,4-oxadiazoles
DE68917709D1 (de) Verfahren zur Herstellung eines Pertussis-Toxin-Toxoides.
FI884960A (fi) Anvaendning av 2-pyrimidinyl-1-piperazin-derivat.
DE68917972D1 (de) Pertussistoxoid-Impfstoff.
DK0454494T3 (da) Calicheamicinoner, derivater deraf og analoge dertil og fremgangsmåde til fremstilling af disse
SE7801527L (sv) 2,4-diklorfenyl-triazolyl-etan-oner(oler) till anvendning som fungicider och sett att framstella foreningarna
FR2601250B1 (fr) Procede de preparation de fractions antigeniques exocellulaires de bordetella pertussis et vaccin contre la coqueluche contenant de telles fractions.
JPS5359023A (en) Inactivation of toxins produced by microbials and attenuation of vaccines
JPS53109912A (en) Condensed tannin, inactivation of microorganism-originated toxic substance, and attenuation of vaccines using condensed tannin

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910702

FG3A Patent granted, date of granting

Effective date: 19980406

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20130408